- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02330718
Prospective and Retrospective Cohort Study to Find New Prognostic Factors and Therapeutic Targets in Patients With Newly Diagnosed or Relapsed Malignant Hematologic Disorder Excluding Acute Leukemia
February 21, 2019 updated by: Yonsei University
The purpose of this study is to elucidate the factors which are associated with the diagnosis and predict prognosis and therapeutic targets by collecting specimens of tissue sample, peripheral blood, and bone marrow aspirates at the time of diagnosis or relapse/refractory in patients with malignant hematologic disorders except acute leukemia.
This study is eligible for patients who are diagnosed with malignant hematologic disorders except acute leukemia or who will have diagnostic procedure with suspicion of having hematologic malignancy.
Prospective cohort is for patients who are not in treatment for hematologic malignancy.
Retrospective cohort is for patients who are diagnosed and in treatment.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
1500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 120-752
- Recruiting
- Severance Hospital
-
Contact:
- Jin-Seok Kim, MD, Ph.D
- Phone Number: 82-2-2228-1972
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with newly diagnosed or relapsed malignant hematologic disorders except acute leukemia
Description
Inclusion Criteria:
- The patients with malignant hematologic disorders except acute leukemia who are diagnosed pathologically according to the revised 2008 WHO classification of tumours of haematopoietic and lymphoid tissue or who will have diagnostic procedure with suspicion of having hematologic malignancy.
- Any gender and age ≥ 19 years
- Written informed consent
- Diagnosed after 2005-01-01 in retrospective cohort group.
Exclusion Criteria:
- Patients who cannot understand or disagree the informed consent
- Patients who diagnosed with acute leukemia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Other
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the number of patients with malignant hematologic disorders to examine the new prognostic factors and therapeutic targets
Time Frame: 5 years
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2014
Primary Completion (Anticipated)
December 1, 2019
Study Completion (Anticipated)
April 1, 2020
Study Registration Dates
First Submitted
December 29, 2014
First Submitted That Met QC Criteria
December 31, 2014
First Posted (Estimate)
January 5, 2015
Study Record Updates
Last Update Posted (Actual)
February 22, 2019
Last Update Submitted That Met QC Criteria
February 21, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4-2014-0236
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malignant Hematologic Disorder
-
Roswell Park Cancer InstituteCompletedMalignant Neoplasm | Parent | Hematologic and Lymphocytic Disorder | GuardianUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Neoplasm | Immune System Disorder | Healthy Subject | Hematologic and Lymphocytic DisorderUnited States
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Sixth Affiliated Hospital...Unknown
-
Memorial Sloan Kettering Cancer CenterTerminated
-
UNC Lineberger Comprehensive Cancer CenterGenentech, Inc.CompletedHematologic Malignancies | Malignant Solid TumorUnited States
-
Aalborg University HospitalUnknownMalignant Hematologic NeoplasmDenmark
-
University Hospital, BrestRecruitingMDS | ALL | Other Hematologic Malignant NeoplasmsFrance
-
UNC Lineberger Comprehensive Cancer CenterCompletedMalignant Solid Tumour | Hematologic Malignancies | Planned Hematopoietic Cell TransplantationUnited States
-
Fred Hutchinson Cancer CenterRecruitingNon-Neoplastic Hematologic and Lymphocytic DisorderUnited States
-
Lawson Health Research InstituteUnknownMalignant Hematologic NeoplasmCanada
Clinical Trials on No intervention
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
University of PittsburghCompletedChronic Low Back PainUnited States